Gene · 64006
Papers4,423
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
741 to 760 of 4,423
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Antimicrobial Effectiveness of an Usnic-Acid-Containing Self-Decontaminating Coating on Underground Metro Surfaces in Athens. | Microorganisms | 2022 | 36422303 | PubTator, text mining | PubMed |
| Review of Developments in Combating COVID-19 by Vaccines, Inhibitors, Radiations, and Nonthermal Plasma. | Curr Issues Mol Biol | 2022 | 36421668 | PubTator, text mining | PubMed |
| Sylvatic Transmission of Chikungunya Virus among Nonhuman Primates in Myanmar. | Emerg Infect Dis | 2022 | 36417997 | PubTator, text mining | PubMed |
| Shared 6mer Peptides of Human and Omicron (21K and 21L) at SARS-CoV-2 Mutation Sites. | Antibodies (Basel) | 2022 | 36412834 | PubTator, text mining | PubMed |
| The Potential Protective Role of GS-441524, a Metabolite of the Prodrug Remdesivir, in Vaccine Breakthrough SARS-CoV-2 Infections. | Intensive Care Res | 2022 | 36407474 | PubTator, text mining | PubMed |
| Activation of distinct antiviral T-cell immunity: A comparison of bi- and trispecific T-cell engager antibodies with a chimeric antigen receptor targeting HBV envelope proteins. | Front Immunol | 2022 | 36405686 | PubTator, text mining | PubMed |
| Omicron BA.2 lineage predominance in severe acute respiratory syndrome coronavirus 2 positive cases during the third wave in North India. | Front Med (Lausanne) | 2022 | 36405589 | PubTator, text mining | PubMed |
| Biosensors based detection of novel biomarkers associated with COVID-19: Current progress and future promise. | Biosens Bioelectron X | 2022 | 36405494 | PubTator, text mining | PubMed |
| Neutralization of SARS-CoV-2 Omicron sublineages by 4 doses of the original mRNA vaccine. | Cell Rep | 2022 | 36402138 | PubTator, text mining | PubMed |
| Comparison of the performance of two real-time fluorescent quantitative PCR kits for the detection of SARS-CoV-2 nucleic acid: a study based on large real clinical samples. | Virol J | 2022 | 36401275 | PubTator, text mining | PubMed |
| COVID-19 can lead to rapid progression of cervical intraepithelial neoplasia by dysregulating the immune system: A hypothesis. | J Reprod Immunol | 2022 | 36399874 | PubTator, text mining | PubMed |
| SARS-CoV-2 tetrameric RBD protein blocks viral infection and induces potent neutralizing antibody response. | Front Immunol | 2022 | 36389744 | PubTator, text mining | PubMed |
| SARS-CoV-2 modulates inflammatory responses of alveolar epithelial type II cells via PI3K/AKT pathway. | Front Immunol | 2022 | 36389723 | PubTator, text mining | PubMed |
| COVID-19 and its genomic variants: Molecular pathogenesis and therapeutic interventions. | EXCLI J | 2022 | 36381644 | PubTator, text mining | PubMed |
| Systems biology approach reveals a common molecular basis for COVID-19 and non-alcoholic fatty liver disease (NAFLD). | Eur J Med Res | 2022 | 36380355 | PubTator, text mining | PubMed |
| Persistent Laplacian projected Omicron BA.4 and BA.5 to become new dominating variants. | Comput Biol Med | 2022 | 36379191 | PubTator, text mining | PubMed |
| Validation of RT-qPCR test for SARS-CoV-2 in saliva specimens. | J Infect Public Health | 2022 | 36371937 | PubTator, text mining | PubMed |
| SARS-CoV-2 detection by targeting four loci of viral genome using graphene oxide and gold nanoparticle DNA biosensor. | Sci Rep | 2022 | 36371566 | PubTator, text mining | PubMed |
| Evolutionary Signals in Coronaviral Structural Proteins Suggest Possible Complex Mechanisms of Post-Translational Regulation in SARS-CoV-2 Virus. | Viruses | 2022 | 36366566 | PubTator, text mining | PubMed |
| Molecular Dynamics Simulations to Decipher the Role of Phosphorylation of SARS-CoV-2 Nonstructural Proteins (nsps) in Viral Replication. | Viruses | 2022 | 36366534 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/64006/papers?page=38